07:00 , Aug 17, 2009 |  BC Week In Review  |  Company News

BioAnaLab, Millipore deal

Millipore will acquire CRO BioAnaLab for an undisclosed sum. BioAnaLab provides assay transfer and development, validation and sample analysis, pharmacokinetics, immunogenicity, biological potency and vaccine services. Millipore said the deal will expand its biopharmaceutical services...
07:00 , Jul 24, 2006 |  BC Week In Review  |  Company News

BioAnaLab Ltd. board of directors update

BioAnaLab Ltd. , Oxford, U.K.   Business: Supply/Service   Appointed: David Oxlade, former CEO of Xenova Group plc , as chairman  ...
08:00 , Dec 23, 2002 |  BC Week In Review  |  Company News

BioAnaLab Ltd, Ilex deal

ILXO exclusively sublicensed to BioAnaLab diagnostic rights to Campath and CD52 antigen testing in Europe, the Middle East and Israel. BioAnaLab is a spinout of the Therapeutic Antibody Centre (TAC) at the University of Oxford....